Report copyright - Acute Myelogenous Leukemia: New Therapies after 40 Years! · 2019. 7. 24. · 12/ 33/ 53 . 7 / 41/ 52 : ELN Risk Group (AML) (%) Favorable : Int I/II . Adverse . 6. 35 / 27 . 32
Please pass captcha verification before submit form
Please pass captcha verification before submit form